AC-Selank + DSIP | 15 Mg Pen

Selank is a synthetic peptide studied for its role in anxiolytic and cognitive-regulation pathways, while DSIP (Delta Sleep-Inducing Peptide) is studied for its involvement in sleep modulation and circadian-related signaling. Together, this combination is evaluated in research models focused on neuroregulation, stress response, and sleep architecture. Information on this page is provided for scientific and educational context only and does not represent medical guidance or therapeutic claims.
SUPPORTS
Neurotransmitter regulation assessed via GABAergic and serotonergic signaling pathways.
Stress-response modulation studied through anxiolytic and neuroregulatory endpoints.
Sleep architecture evaluated via circadian and deep-sleep signaling frameworks.
Cognitive function assessed through focus, memory, and mental-performance models.
Central nervous system balance measured in neuroendocrine and behavioral research contexts.
DESCRIPTION
Selank is a synthetic peptide derived from tuftsin analog research, studied for its potential effects on anxiety modulation, cognitive function, and neurotransmitter balance. It has been explored in models involving GABA and serotonin signaling pathways, where anxiolytic and nootropic effects are evaluated. DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring peptide studied for its involvement in sleep regulation and circadian rhythm signaling. Research has investigated its role in promoting deep sleep states and modulating stress-related hormonal activity. When combined, Selank and DSIP form a dual-pathway neuroregulatory system studied for its effects on stress, cognitive balance, and sleep quality. This product is presented for controlled research and educational context only and is not marketed as a therapeutic intervention.
CLINICAL STATUS
Selank has been studied in human and preclinical research settings, particularly in neuroregulation and anxiety-related models. DSIP research is primarily preclinical and mechanistic, with limited and variable human data. The combination remains within experimental research contexts and is not approved as a general therapeutic product.
Evidence type: Human RCT ✔ (Selank) | Observational ✔ | Animal ✔ | In vitro ✔ | Regulatory approval ✘
MECHANISM OF ACTION
Mechanistic models of Selank focus on modulation of GABAergic and serotonergic signaling pathways, influencing anxiety-related responses and cognitive function. DSIP is studied for its interaction with sleep-regulation systems, including circadian rhythms and neuroendocrine pathways involved in sleep onset and depth. Together, these peptides are evaluated as a neuroregulatory combination influencing central nervous system balance, stress-response pathways, and sleep-related signaling. Effects are typically measured through neurotransmitter activity, behavioral models, and sleep-pattern analysis.
BENEFITS
Neuroregulation Support: Selank and DSIP are studied for their combined effects on central nervous system balance.
Stress Response Modulation: Research indicates effects on anxiety-related pathways and stress signaling.
Sleep Quality Research: DSIP is evaluated for its role in deep-sleep and circadian regulation models.
Cognitive Function Studies: Selank has been studied for effects on focus, memory, and mental clarity.
Neurotransmitter Balance: Investigated in models involving GABA and serotonin signaling.
Dual-System Synergy: Combines cognitive regulation with sleep modulation pathways in research frameworks.
RESEARCH DATA
Study/model | Reported effect
Human Selank studies | Reduced anxiety markers and improved cognitive parameters observed
DSIP preclinical studies | Modulation of sleep patterns and circadian signaling
Neurotransmitter models | Changes in GABA and serotonin activity
Behavioral research | Improved stress-response and cognitive performance endpoints

STACK SUGGESTIONS
Melatonin (sleep-cycle and circadian research frameworks)
Magnesium (neurological and relaxation pathway studies)
NAD+ (cellular energy and neuroregulation models)
Stacks discussed are for experimental design only, not safety or efficacy guidance.

POSSIBLE SIDE EFFECTS
Mild fatigue or relaxation effects depending on protocol
Transient neurological adjustments
Injection-site reactions including redness or discomfort
Responses vary depending on experimental conditions

SCIENTIFIC REFERENCES
Selank neuroregulation studies — Human and preclinical research
DSIP sleep modulation research — Mechanistic studies
Neurotransmitter signaling models — Experimental data
Sleep and stress-response pathways — Translational research

CAUTIONS
For educational and scientific context only; not intended to diagnose, treat, cure, or prevent any disease. Not approved for general medical use. Outcomes vary based on experimental design and neurological conditions. Consult a qualified professional for any health-related decisions.